Seniors Guardian: A Monitoring Platform for the Elderly (SEMONE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03891771 |
Recruitment Status :
Completed
First Posted : March 27, 2019
Last Update Posted : November 22, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Quality of Life | Device: Telemonitoring sensors | Not Applicable |
Elderly participants at perceived socioeconomic risk will be randomised in a 1:1 ratio to receive either a telemonitoring platform in their houses or standard health care. The platform will include sensors able to detect falls, nocturia (which have been previously validated) and sensors for environmental variables including humidity, carbon monoxide levels and temperature. In addition, a wearable panic button will be provided for participants allocated to the sensor platform which will allow them to obtain help in case of an emergency. The sensor platform will be connected to emergency services and healthcare providers,and they should receive and react to any anomaly detected in their readings.
Participants will be followed up for 10 months. Quality of life questionnaires, including the World Health Organisation's WHOQOL-BREF and the EQ-5D for health-related quality of life, will be used to address potential intervention effects.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 69 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Supportive Care |
Official Title: | Seniors Guardian: A Non-intrusive Monitoring Platform for Activities of Daily Living Amongst the Elderly |
Actual Study Start Date : | April 30, 2019 |
Actual Primary Completion Date : | June 6, 2021 |
Actual Study Completion Date : | June 6, 2021 |
Arm | Intervention/treatment |
---|---|
No Intervention: Usual Care
Patients allocated to usual care will receive standard follow-up procedures at their primary care facility.
|
|
Experimental: Telemonitoring sensors
Patients allocated to this arm will receive a complex sensor platform aimed at detecting falls at home, nocturia and several environmental variables, including carbon monoxide concentrations, humidity and temperature. The system also includes a panic button that can be used to request assistance in emergencies.
|
Device: Telemonitoring sensors
This complex platform entails several sensors aimed at detecting falls, nocturia and environmental variables in the participant's home. Sensors are non-intrusive and its only wearable component is the panic button which must be carried by the participant. |
- Overall Quality of Life score as measured by the World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF) [ Time Frame: 1 month after randomisation ]This scale is designed to assess the overall quality of life of the respondent using 5-point Likert scales. Higher scores mean a better quality of life. WHOQOL-BREF is divided in 4 domains, including physical health, psychological, social relationships and environment. The mean score for each domain is used to calculate the domain score. Scores can then be added together to obtain an overall score. Therefore, scores in the WHOQOL-BREF questionnaire range from 4 to 20 points.
- Overall Quality of Life score as measured by the World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF) [ Time Frame: 5 months after randomisation ]This scale is designed to assess the overall quality of life of the respondent using 5-point Likert scales. Higher scores mean a better quality of life. WHOQOL-BREF is divided in 4 domains, including physical health, psychological, social relationships and environment. The mean score for each domain is used to calculate the domain score. Scores can then be added together to obtain an overall score. Therefore, scores in the WHOQOL-BREF questionnaire range from 4 to 20 points.
- Overall Quality of Life score as measured by the World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF) [ Time Frame: 10 months after randomisation ]This scale is designed to assess the overall quality of life of the respondent using 5-point Likert scales. Higher scores mean a better quality of life. WHOQOL-BREF is divided in 4 domains, including physical health, psychological, social relationships and environment. The mean score for each domain is used to calculate the domain score. Scores can then be added together to obtain an overall score. Therefore, scores in the WHOQOL-BREF questionnaire range from 4 to 20 points.
- Health-Related Quality of Life score using the EuroQOL-5D (EQ-5D) Questionnaire [ Time Frame: 1 month after randomisation ]EuroQol-5D (EQ-5D) is a standardised questionnaire that allows to quantify health-related quality of life. It is divided in two sections, a descriptive section and a visual analogue scale (VAS) at the end of the questionnaire. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The EQ-VAS records the patient's self-rated health on a vertical visual analogue scale. Results are presented as a descriptive profile or as an index value calculated from the descriptive component which is country-specific. Visual analog values can range from 0 to 100, with higher values indicating an overall better health-related quality of life.
- Health-Related Quality of Life score using the EuroQOL-5D (EQ-5D) Questionnaire [ Time Frame: 5 months after randomisation ]EuroQol-5D (EQ-5D) is a standardised questionnaire that allows to quantify health-related quality of life. It is divided in two sections, a descriptive section and a visual analogue scale (VAS) at the end of the questionnaire. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The EQ-VAS records the patient's self-rated health on a vertical visual analogue scale. Results are presented as a descriptive profile or as an index value calculated from the descriptive component which is country-specific. Visual analog values can range from 0 to 100, with higher values indicating an overall better health-related quality of life.
- Health-Related Quality of Life score using the EuroQOL-5D (EQ-5D) Questionnaire [ Time Frame: 10 months after randomisation ]EuroQol-5D (EQ-5D) is a standardised questionnaire that allows to quantify health-related quality of life. It is divided in two sections, a descriptive section and a visual analogue scale (VAS) at the end of the questionnaire. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The EQ-VAS records the patient's self-rated health on a vertical visual analogue scale. Results are presented as a descriptive profile or as an index value calculated from the descriptive component which is country-specific. Visual analog values can range from 0 to 100, with higher values indicating an overall better health-related quality of life.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Elderly participant (>65 years of age) perceived to be at socioeconomic risk
- Resident in the city of Valparaiso or San Antonio
- Lives alone
- Obtained a housing subsidy from the Servicio de Vivienda y Urbanismo (Housing and Urbanism Services)
Exclusion Criteria:
- Dementia
- Substance or alcohol abuse
- Inability to answer quality of life questionnaires due to medical or psychiatric morbidity
- Terminal illness (life expectancy under 6 months)
- Ownership of pets within the residence (ie. dogs, cats).
- Refusal to participate

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03891771
Chile | |
Centro de Salud Familiar 30 de Marzo | |
San Antonio, Chile | |
Centro de Salud Familiar Barrancas | |
San Antonio, Chile | |
Centro de Salud Familiar Nestor Fernandez | |
San Antonio, Chile | |
Centro de Salud Familiar San Antonio | |
San Antonio, Chile |
Study Chair: | Carla Taramasco, Ph.D. | Universidad de Valparaiso | |
Principal Investigator: | Felipe T Martinez, M.D., M.Sc | Universidad Andres Bello |
Publications:
Responsible Party: | Universidad de Valparaiso |
ClinicalTrials.gov Identifier: | NCT03891771 |
Other Study ID Numbers: |
CEC181-18 |
First Posted: | March 27, 2019 Key Record Dates |
Last Update Posted: | November 22, 2021 |
Last Verified: | October 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Elderly Activities of daily living Telemonitoring |